Clinical effectiveness of nemifitide, a novel pentapeptide antidepressant, in depressed outpatients: comparison of follow-up re-treatment with initial treatment.

@article{Feighner2003ClinicalEO,
  title={Clinical effectiveness of nemifitide, a novel pentapeptide antidepressant, in depressed outpatients: comparison of follow-up re-treatment with initial treatment.},
  author={John Preston Feighner and Lev S Sverdlov and Gabriela Valente Nicolau and Henry Baxter Abajian and Joseph J. Hlavka and Jeffrey Stephen Freed and George Tonelli},
  journal={The international journal of neuropsychopharmacology},
  year={2003},
  volume={6 3},
  pages={
          207-13
        }
}
Data from two Phase 2 clinical studies with nemifitide, a novel pentapeptide antidepressant, were evaluated. The initial double-blind, placebo-controlled study was performed on outpatients with DSM-IV criteria for major depressive disorder. An open-label extension study enrolled subjects either completing or having been discontinued due to lack of efficacy during the follow-up period of the initial study. In the extension study, both the investigator and the subjects were blinded to the… CONTINUE READING
BETA

Similar Papers

Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-2 OF 2 CITATIONS